Engineering substrate promiscuity in halophilic alcohol dehydrogenase (HvADH2) by in silico design

An alcohol dehydrogenase from the halophilic archaeon Haloferax volcanii (HvADH2) has been engineered by rational design to broaden its substrate scope towards the conversion of a range of aromatic substrates, including flurbiprofenol, that is an intermediate of the non-steroidal anti-inflammatory drug, flurbiprofen. Wild-type HvADH2 showed minimal activity with flurbiprofenol (11.1 mU/mg). A homology model of HvADH2 was built and docking experiments with this substrate revealed that the biphenyl rings of flurbiprofenol formed strong interactions with residues F85 and F108, preventing its optimal binding in the active site. Mutations at position 85 however did not increase activity. Site directed mutagenesis at position F108 allowed the identification of three variants showing a significant (up to 2.3-fold) enhancement of activity towards flurbiprofenol, when compared to wild-type HvADH2. Interestingly, F108G variant did not show the classic inhibition in the presence of (R)-enantiomer when tested with rac-1-phenylethanol, underling its potential in racemic resolution of secondary alcohols.

Medienart:

E-Artikel

Erscheinungsjahr:

2017

Erschienen:

2017

Enthalten in:

Zur Gesamtaufnahme - volume:12

Enthalten in:

PloS one - 12(2017), 11 vom: 20., Seite e0187482

Sprache:

Englisch

Beteiligte Personen:

Cassidy, Jennifer [VerfasserIn]
Bruen, Larah [VerfasserIn]
Rosini, Elena [VerfasserIn]
Molla, Gianluca [VerfasserIn]
Pollegioni, Loredano [VerfasserIn]
Paradisi, Francesca [VerfasserIn]

Links:

Volltext

Themen:

Alcohol Dehydrogenase
EC 1.1.1.1
Journal Article

Anmerkungen:

Date Completed 26.12.2017

Date Revised 13.11.2018

published: Electronic-eCollection

Citation Status MEDLINE

doi:

10.1371/journal.pone.0187482

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM278562701